About MT Capital
MT Capital is a venture capital firm located in Zurich, Switzerland. It primarily invests in Switzerland based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Overall, MT Capital portfolio has seen 5 IPOs and 1 acquisition including key companies like ABB, Nestle and Novartis. MT Capital has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Portfolio Acquisitions
MT Capital's List of Top Investments
MT Capital has a portfolio of 6 companies. Their most notable investments include ABB and Nestle.Their portfolio spans across Switzerland and Australia. They have invested in Life Sciences, High Tech, Enterprise Applications and 6 other sectors. Here is the list of top investments by MT Capital:1. ABB
Provider of electrification and automation technologies for industrial applications. The company offers integrated solutions that digitalize, automate, and electrify processes across various sectors, including energy, marine, and manufacturing. Its portfolio includes motors, drives, power converters, controllers, and robotics systems designed to enhance productivity, efficiency, and sustainability. By combining engineering and digitalization expertise, the company supports the transition to cleaner energy and improved operational performance.
Key facts about ABB
- Founded Year: 1883
- Location: Zurich (Switzerland)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Employee Count: 151,001 as on Jul 31, 2026
- Investors: ngn-capital.com, GIC and 17 Others
- Latest Funding Round: Grant (prize money), Nov 01, 2023, $*****
- Highlight: Public
2. Nestle
Internet first brand of multi category food and beverage products. It products include coffee, tea, candy, confectionery, bottled water, infant formula, dairy products, frozen, breakfast cereals, snacks, pet, and medical food. It has several businesses such as nestle health science, nestle skin health, and nestle purina pet care company. In 2022, the company recorded annual revenues of $98.87B and a net profit of $9.71B.
Key facts about Nestle
- Founded Year: 1866
- Location: Vevey (Switzerland)
- Annual Revenue: ₹1,000+ Cr as on Mar 31, 2026
- Stage: Public
- Employee Count: 218,543 as on Jun 30, 2026
- Investors: SIZE, Runway and 12 Others
- Latest Funding Round: Grant (prize money), Sep 28, 2023, $*****
- Highlight: Public
3. Novartis
R&D focused on manufacturing of drugs for multiple therapeutic areas. The Company segments include Pharmaceuticals, which researches, develops, manufactures, distributes, and sells prescription medicines in the therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience, and established medicines; Alcon, which operates through over three franchises Surgical, Ophthalmic Pharmaceuticals and Vision Care, and Sandoz, which develops, manufactures and markets generic pharmaceutical products, follow-on biopharmaceutical products known as biosimilars, and other drug substances.
Key facts about Novartis
- Founded Year: 1996
- Location: Basel (Switzerland)
- Annual Revenue: $0 - $1M as on Dec 31, 2017
- Stage: Acquired
- Employee Count: 86,741 as on Aug 31, 2026
- Investors: Digital Pharma Lab, Atlas Venture and 9 Others
- Latest Funding Round: Grant (prize money), Dec 01, 2018, $*****
- Highlight: Acquired
4. Roche
Developer of pharmaceuticals and diagnostics kits for multiple diseases. It manufactures diagnostic equipment and reagents for research and medical diagnostic applications. In 2022, the company recorded annual revenues of $66.26B and a net profit of $13.01B
Key facts about Roche
- Founded Year: 1896
- Location: Basel (Switzerland)
- Annual Revenue: £10M - £50M as on Jul 31, 2022
- Stage: Public
- Employee Count: 107,716 as on Aug 31, 2026
- Investors: Gilde Healthcare, SoftBank Group and 12 Others
- Latest Funding Round: Post IPO, May 21, 2023, $*****
- Highlight: Public
5. Zurich
Global multi-line insurer offering a range of general insurance and life insurance solutions to individuals, small businesses, and large corporations. It focuses on general insurance and life insurance solutions for individuals, small businesses, medium-sized businesses, and large companies, including multinational corporations. The company provides specialized insurance services across various industries, enabling businesses to manage and mitigate potential disruptions and minimize impacts. It offers a suite of insurance products designed to cater to the needs of individuals, including life, income protection, and home loan protection, ensuring financial security and peace of mind for policyholders.
Key facts about Zurich
- Founded Year: 1869
- Location: Zurich (Switzerland)
- Annual Revenue: $0 - $1M as on Dec 31, 2025
- Stage: Public
- Employee Count: 46,551 as on Sep 30, 2026
- Investors: MT Capital, Nex Cubed and 1 Other
- Latest Funding Round: Grant (prize money), Jan 01, 2024, $*****
- Highlight: Public
IPOs and Publicly Listed companies in MT Capital's Portfolio
5 of MT Capital's portfolio companies have become public. Nestle got listed on the National Stock Exchange (NSE), in Jan 2010 and Roche got listed on the OTC Markets (OTCMKTS) at marketcap of undefined.Here are MT Capital's portfolio companies that went public:
Filter this listCompany | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 08, 2010 | - | - | 4925 | |
Dec 05, 2002 | - | - | 4836 | |
Nov 08, 2000 | - | - | 6724 | |
Aug 04, 1995 | - | - | 6010 | |
Jun 28, 1962 | - | - | 5808 |
Acquired companies in MT Capital's Portfolio
1 company from MT Capital's portfolio has been acquired. The most recent acquisition was Novartis in Feb 2026 by ChrysCapital for $*****.Here are MT Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 21, 2026 | - | - | 1684 |
